PMC:7456455 / 33145-33333
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T407 | 93-104 | Body_part | denotes | macrophages | http://purl.org/sig/ont/fma/fma63261 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T204 | 119-125 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T459 | 6-7 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T171 | 0-2 | Chemical | denotes | SG | http://purl.obolibrary.org/obo/CHEBI_74814 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T207 | 0-140 | Sentence | denotes | SG is a consultant to Verseau and to Myeloid Therapeutics, both exploiting Tumour associated macrophages for potential cancer immunotherapy. |
| T208 | 141-188 | Sentence | denotes | Other authors declare no conflicts of interest. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T47 | 75-81 | Phenotype | denotes | Tumour | http://purl.obolibrary.org/obo/HP_0002664 |
| T48 | 119-125 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T851 | 37-44 | CL:0000763 | denotes | Myeloid |
| T852 | 93-104 | CL:0000235 | denotes | macrophages |
| T32654 | 93-104 | CL:0000235 | denotes | macrophages |
| T55177 | 37-44 | CL:0000763 | denotes | Myeloid |
| T10700 | 93-104 | CL:0000235 | denotes | macrophages |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 736 | 22-29 | Chemical | denotes | Verseau | |
| 737 | 119-125 | Disease | denotes | cancer | MESH:D009369 |